Vancouver Coastal Health
Vancouver, British Columbia, V5Z 1M9, Canada
NCT Number: NCT02804620
This study is a 12-month study. There are two different groups in the study. Both groups will enter the study after the graduation from 8-hour diabetes education course taught at VGH, St. Paul's, or Richmond Hospital. The first group will receive on-going support from their peers who have diabetes and are trained specifically to help other patients with diabetes. The second group will receive the usual care.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Vancouver, British Columbia, V5Z 1M9, Canada
This two-phase study is a randomized controlled trial (RCT) comparing usual care to a 12-month peer-led DSMS intervention designed to improve long-term diabetes-related health outcomes.
In Phase 1, the research team will implement a 30-hour peer leader training (PLT) program recruiting adults with type 2 diabetes and equipping them with the diabetes knowledge, facilitation strategies, and communication skills to deliver a DSMS intervention. In Phase 2, the researchers will conduct the peer support intervention, referred to as the Peer-Led, Empowerment-based Approach to Self-management Efforts in Diabetes (PLEASED). Patients randomized to the PLEASED arm will be paired with a peer leader and receive 12 weekly contacts (face-to-face and telephone support) from their peer leader (PL) in the first 3 months followed by 18 bi-weekly telephone support contacts over the last 9 months.
The goal of the PLEASED intervention is to help patients improve glycemic control and diabetes specific QOL and sustain these health benefits over the long-term. To achieve this goal, PLs will address 3 key functions of peer support that include assisting patients in the daily management of their diabetes, providing social and emotional support, and linking patients to clinical care resources.
Participants' inclusion criteria are: to (1) have type 2 diabetes, (2) be 21 years, (3) speak English or Vietnamese or any languages that their peer leaders speak, (4) be willing to be matched with a peer leader, and (5) have a personal land line telephone or mobile phone.
Peer leaders' inclusion criteria are: (1) have diabetes, (2) be 21 years, (3) speak English, (4) have transportation to attend training, (5) be willing to commit to a 30-hour training program, and (6) have a land line telephone or mobile phone (7) have a self-reported HbA1c of 8% or less.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Participants:
Exclusion criteria
for Participants:
Inclusion criteria
for Peer Leaders:
Exclusion criteria
for Peer Leaders:
The investigators will train patients with type 2 diabetes who are well-controlled and pair them up with participants. Peer leaders will help the participants overcome their problems and teach them how to make changes by 5 step goal setting strategy. The peer leaders never give advice on any medical condition. All the medical questions will be referred to the research team.
Other names: PLEASED
Time frame: 0, 3, 12 month(s)
Time frame: 0, 3, 12 month(s)
Time frame: 0, 3, 12 month(s)
Time frame: 0, 3, 12 month(s)
Time frame: 0, 3, 12 month(s)
Time frame: 0, 3, 12 month(s)
University of British Columbia
Other
From Clinic to Community: Using Peer Support as a Transition Model for Improving Long-term Diabetes-related Health Outcomes
Acronym: C2C
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05586308
Behavior, Behavior, Health Risk
Omaha, Nebraska, United States
View Trial DetailsNCT04797429
Diabetes Mellitus, Diabetes Mellitus, Type 2
Sankt Pölten, Lower Austria, Austria
View Trial DetailsNCT06366620
Challenging Behavior, Child Behavior Problems
Seattle, Washington, United States
View Trial DetailsNCT06064955
Brain Diseases, Central Nervous System Diseases
Columbus, Ohio, United States
View Trial Details